Over 120 residents in Qatar suffer from rare bleeding disorders
In recognition of World Hemophilia Day (WHD), Hamad Medical Corporation (HMC) recently hosted a two-day event to raise awareness about hemophilia, a group of inherited bleeding disorders.
Dr. Ahmed Abdulaziz, Clinical Pharmacist at Hamad General Hospital stated: “Hemophilia occurs due to defects in the body’s blood vessels or the coagulation mechanism, which is responsible for coagulating (clotting) blood from a liquid into a solid, after surgery or injury.
“An affected individual does not bleed more profusely or faster than other people, however, he bleeds for a longer time. These hemorrhages commonly occur in joints, especially knees, ankles and elbows, and into tissues and muscles.”
He highlighted that a comprehensive care clinic located in HGH provides all required medical services to affected individuals and their families. This includes basic treatment to stop or prevent bleeding, known as the factor replacement therapy that involves injecting the medication into the patient’s bloodstream.
“Presently, over 120 patients with rare bleeding disorders, including children and adults, receive medication (clotting factor) from pharmacies at HGH and the National Center for Cancer Care and Research (NCCCR). Although medication is expensive, dedicated staff from HGH’s Pharmacy and Pediatric Hematology/Oncology services ensures that adequate supply is maintained at all times,” added Dr. Abdulaziz.
[Photo courtesy: Mattia Belletti via Flickr]